90792-69-1 Usage
Uses
Used in Organic Synthesis:
Methyl 2-chlorobenzo[d]thiazole-6-carboxylate is used as a building block in organic synthesis for the creation of various pharmaceuticals and agrochemicals. Its unique structure and reactivity make it a valuable component in the synthesis of complex organic molecules.
Used in Drug Discovery:
In the pharmaceutical industry, methyl 2-chlorobenzo[d]thiazole-6-carboxylate is used as a key intermediate in the development of new drugs. Its potential biological activities and presence of the thiazole ring, a common structural motif in biologically active compounds, contribute to its utility in drug discovery and design.
Used in Agrochemical Development:
Methyl 2-chlorobenzo[d]thiazole-6-carboxylate is also utilized in the agrochemical industry as a building block for the synthesis of various agrochemicals. Its versatility and reactivity make it suitable for the development of new agrochemicals with improved properties and efficacy.
Check Digit Verification of cas no
The CAS Registry Mumber 90792-69-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,7,9 and 2 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 90792-69:
(7*9)+(6*0)+(5*7)+(4*9)+(3*2)+(2*6)+(1*9)=161
161 % 10 = 1
So 90792-69-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H6ClNO2S/c1-13-8(12)5-2-3-6-7(4-5)14-9(10)11-6/h2-4H,1H3
90792-69-1Relevant academic research and scientific papers
TLR2 MODULATOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
-
Paragraph 001481-001482, (2021/12/08)
The present disclosure relates to compounds which modulate the activity of Toll-like receptor (TLR) proteins, including agonists or activators, partial agonists, and antagonists. Of particular interest of compounds that modulate the activity of TLR2, as well as methods of using such compounds to treat cancer and other disorders associated with a TLR2 pathway.
FXR regulator with spirane structure
-
, (2019/01/14)
The invention provides a new compound which has certain agonist activity on a Farnesoid X receptor (FXR) and is used for treating FXR mediated diseases and/or symptoms such as liver disease and gastrointestinal disease. (The formula is shown in the description.).
NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AS FXR MODULATORS
-
Paragraph 0112; 0113, (2018/05/24)
The present technology is directed to compounds, compositions, and methods related to modulation of FXR. In particular, the present compounds and compositions may be used to treat FXR-mediated disorders and conditions, including, e.g., liver disease, hype
